Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric monoclonal antibody against claudin-18 splice variant 2

EU orphan designation number: EU/3/10/803   
Active ingredient: Chimeric monoclonal antibody against claudin-18 splice variant 2
Indication: Treatment of gastric cancer
Sponsor: GANYMED Pharmaceuticals AG
Freiligrathstraße 12, D-55131 Mainz, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Centralised Orphan - Designation EMA/OD/083/10 (2010)8587 of 26/11/2010